F830116E18Rik Activators
Hemoglobin, theta 1B Activators are compounds that indirectly enhance the functional activity of hemoglobin, theta 1B by influencing the expression and assembly of hemoglobin subunits or by altering the hemoglobin affinity for oxygen. Compounds like Hydroxyurea and Hydroxycarbamide are known to induce the production of fetal hemoglobin, which can result in a change in the overall hemoglobin composition in red blood cells and indirectly increase the functional activity of hemoglobin, theta 1B. Similarly, Butyrate and Arginine Butyrate are short-chain fatty acids that have been shown to enhance the expression of gamma-globin genes. This upregulation can lead to an increase in hemoglobin variants, including hemoglobin, theta 1B, by shifting the balance of hemoglobin types produced in the body.
DNA methyltransferase inhibitors such as 5-Azacytidine and Decitabine can cause hypomethylation of the DNA, which in turn may lead to the upregulation of genes that are normally silenced, including those related to fetal hemoglobin production. This could contribute to an increase in hemoglobin, theta 1B activity. Histone deacetylase inhibitors like Trichostatin A and Valproic Acid can result in a more open chromatin structure and potentially facilitate the expression of hemoglobin-related genes, including that of hemoglobin, theta 1B.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea induces the production of fetal hemoglobin, which can indirectly increase the functional activity of hemoglobin, theta 1B by altering the hemoglobin composition and oxygen affinity in the blood. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can lead to the hypomethylation of DNA, indirectly leading to the upregulation of fetal hemoglobin and potentially increasing the functional activity of hemoglobin, theta 1B. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine acts similarly to 5-Azacytidine by inhibiting DNA methyltransferases, resulting in DNA demethylation and potentially enhancing the expression of hemoglobin, theta 1B. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Pomalidomide affects the ubiquitin-proteasome pathway and can lead to the degradation of specific transcription repressors, indirectly enhancing the expression of hemoglobin, theta 1B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and protein synthesis; this inhibition can lead to altered protein expression profiles, including the potential increase in hemoglobin, theta 1B. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can lead to changes in chromatin structure, potentially increasing the expression of genes related to hemoglobin, including hemoglobin, theta 1B. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, another histone deacetylase inhibitor, can increase the acetylation of histones, leading to a more relaxed chromatin state and potentially higher expression of hemoglobin, theta 1B. | ||||||